Traversa Therapeutics

Development and commercialization of RNAi Delivery Technologies

placeSan Diego, California, United States calendar_todayFounded 2006 language traversathera.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 14 times.

YearFilings
20121

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Angel & family office133%
Other / undisclosed133%
Coming soon